Primary Cytoreduction for Advanced Endometrial Cancer with Rebecca Previs and Benjamin Albright

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez, is joined by Drs. Rebecca Previs and Benjamin Albright to discuss primary cytoreduction for advanced endometrial cancer. Dr. Rebecca Previs is an assistant professor within the Division of Gynecologic Oncology and the Department of Obstetrics & Gynecologic at Duke University Medical Center, Duke Cancer Institute in Durham, NC. Her translational research interests include understanding how the immune microenvironment and molecular characterization of gynecologic cancers influences disease biology and treatment outcomes. Outside of medicine, she enjoys spending time with her menagerie of pets, gardening, hiking, harvesting honey from her bee hives, and playing the piano. Dr. Ben Albright is a second-year fellow within the Division of Gynecologic Oncology and the Department of Obstetrics & Gynecologic at Duke University Medical Center, Duke Cancer Institute in Durham, NC. His research interests include health policy and economics, health services research, systematic review, and cost-effectiveness analysis. Outside of medicine, he enjoys trail running, tennis, hiking with his wife and two big dogs, and University of Kentucky basketball. @BeccaPrevisMD / @BenAlbrightMD / @dukeobgyn / @DukeCancer Highlights 1. The objective of our study was (1) to assess the frequency of reported proportions of maximal (R0, no gross residual disease) and optimal (5. Women with advanced stage endometrial cancer should be encouraged to enroll on clinical trials when available.